Meeting Banner
Abstract #1819

MRI contrast agent for myocardial infarction based on novel manganese-based nanoparticles

Chengbin He1, Xiaoxuan Zhou1, Cailing Pu1, Jingle Fei1, Yan Wu1, and Hongjie Hu1
1Department of Radiology, Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, Hangzhou, China

Gadolinium is a commonly used contrast agent for myocardial infarction during CMR examinations, but its nephrotoxicity and short examination time window limited its application to some extent. We try to develop new contrast agents with superior imaging performance and good biocompatibility, which can achieve clinical translation.

This abstract and the presentation materials are available to members only; a login is required.

Join Here